Related references
Note: Only part of the references are listed.Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database
Alessandro Vitale et al.
GUT (2023)
From NAFLD to MAFLD: Implications of a Premature Change in Terminology
Zobair M. Younossi et al.
HEPATOLOGY (2021)
Methods of Public Health Research - Strengthening Causal Inference from Observational Data
Miguel A. Hernan
NEW ENGLAND JOURNAL OF MEDICINE (2021)
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
Dominik Pfister et al.
NATURE (2021)
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
Dominik Pfister et al.
NATURE (2021)
Redefining non-alcoholic fatty liver disease: what's in a name?
[Anonymous]
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2020)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
An Assessment of Benefits and Harms of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis
Omair Atiq et al.
HEPATOLOGY (2017)
Causal Inference in Public Health
Thomas A. Glass et al.
ANNUAL REVIEW OF PUBLIC HEALTH, VOL 34 (2013)
Structural Nested Cumulative Failure Time Models to Estimate the Effects of Interventions
Sally Picciotto et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2012)